The outrage over prescription drug pricing in the U.S. is justified. Americans routinely pay two to three times more for ...

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

A newly proposed framework expands acute traumatic brain injury (TBI) assessment beyond the Glasgow Coma Scale (GCS).

While rates of bile duct injury were similar with robotic-assisted cholecystectomy and laparoscopic cholecystectomy among ...

And Arcutis Biotherapeutics announced approval of roflumilast (Zoryve) topical foam 0.3% for plaque psoriasis of the scalp ...

With all of the healthcare funding cuts currently going on in Washington, there is one health service that has survived ...

Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

Alpha-synuclein, TDP-43 signatures, and cerebral small vessel disease were common in people with discordant stages. Older ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new insights -- but ...

An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib ...

"Again, I don't want to give advice," Kennedy said. "I can tell you, in Europe, they don't use the chickenpox vaccine ...